secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001628280-24-029340
Event type: other
Sentiment:  neutral
Materiality: 0.04
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics reports 2024 annual meeting voting results
-----------------------------------------------------------------

- Elected Santo J. Costa, Julie Krop, and Marco Taglietti as Class III directors with 24.9M, 21.6M, and 24.9M votes for.
- Non-binding advisory vote on executive compensation approved: 23.6M for, 1.6M against.
- Advisory vote frequency set at one year (24.6M for).
- Ratified KPMG as independent auditor for FY 2024: 50.7M for, 0.9M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024029340/0001628280-24-029340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024029340/aqst-20240620.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-029340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer